Results 141 to 150 of about 53,326 (163)

Case Report: Cutaneous T-cell lymphoma associated with biologic therapy: three cases and a literature review. [PDF]

Front Med (Lausanne)
Li T, Wang G, Zhang C, Wang W, Li C, Wang Y.   +5 more
europepmc   +1 more source

Genetic alteration of class I HLA in cutaneous T-cell lymphoma.

Blood
Kwang AC, Duran GE, Fernandez-Pol S, Najidh S, Li S, Bastidas Torres AN, Wang EB, Herrera M, Bandali TI, Kurtz DM, Kim YH, Khodadoust MS.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly  

Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas.

Journal of Experimental Medicine, 1981
Marjorie Robert-Guroff, V S Kalyanaraman, B J Poiesz   +2 more
exaly  

Cutaneous B-Cell Lymphoma

Hematology/Oncology Clinics of North America, 2019
Amrita Goyal, Robert E Leblanc, Joi B Carter   +2 more
exaly  

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors

Expert Review of Anticancer Therapy, 2010
Richard Piekarz, Cody J Peer, Robin Frye   +2 more
exaly  

Primary cutaneous B-cell lymphomas with large cell predominance–primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma

Seminars in Diagnostic Pathology, 2017
Laura B Pincus
exaly  

Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

Blood, 2019
Lise M Lindahl, Andreas Willerslev-Olsen, Lise Mette Rahbek Gjerdrum   +2 more
exaly  

<p>Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma</p>

OncoTargets and Therapy, 2019
Thomas A Ollila, Ilyas Şahin, Adam J Olszewski   +2 more
exaly